DK0490380T3 - Anvendelse af N,N'-bis[3-(ethylamino)propyl]-1,7-heptandiamin og et cytotoksisk middel - Google Patents
Anvendelse af N,N'-bis[3-(ethylamino)propyl]-1,7-heptandiamin og et cytotoksisk middelInfo
- Publication number
- DK0490380T3 DK0490380T3 DK91121354T DK91121354T DK0490380T3 DK 0490380 T3 DK0490380 T3 DK 0490380T3 DK 91121354 T DK91121354 T DK 91121354T DK 91121354 T DK91121354 T DK 91121354T DK 0490380 T3 DK0490380 T3 DK 0490380T3
- Authority
- DK
- Denmark
- Prior art keywords
- antineoplastic
- heptanediamine
- ethylamino
- propyl
- bis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62681490A | 1990-12-13 | 1990-12-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0490380T3 true DK0490380T3 (da) | 1998-09-23 |
Family
ID=24511975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91121354T DK0490380T3 (da) | 1990-12-13 | 1991-12-12 | Anvendelse af N,N'-bis[3-(ethylamino)propyl]-1,7-heptandiamin og et cytotoksisk middel |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0490380B1 (da) |
JP (1) | JPH04275233A (da) |
KR (1) | KR100195423B1 (da) |
AT (1) | ATE163264T1 (da) |
AU (1) | AU648846B2 (da) |
DE (1) | DE69128926T2 (da) |
DK (1) | DK0490380T3 (da) |
ES (1) | ES2113870T3 (da) |
GR (1) | GR3026432T3 (da) |
IE (1) | IE914331A1 (da) |
ZA (1) | ZA919695B (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0819432B1 (en) * | 1996-01-31 | 2004-03-24 | Japan Science and Technology Corporation | Antitumor agents comprising as the principal agent compounds containing silicon and nitrogen |
US6274561B1 (en) | 1997-01-29 | 2001-08-14 | Japan Science & Technology Corp. | Antitumor agents comprising as the principal compounds containing silicon and nitrogen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1338764C (en) * | 1987-02-03 | 1996-12-03 | David M. Stemerick | Polyamine derivatives |
DK0378146T3 (da) * | 1989-01-10 | 1995-05-01 | Merrell Pharma Inc | Polyamin-derivater som antineoplastiske midler |
AU628174B2 (en) * | 1989-05-23 | 1992-09-10 | Merrell Dow Pharmaceuticals Inc. | A method of potentiating cell-mediated immunity utilizing polyamine derivatives |
-
1991
- 1991-12-09 AU AU88907/91A patent/AU648846B2/en not_active Ceased
- 1991-12-09 ZA ZA919695A patent/ZA919695B/xx unknown
- 1991-12-12 EP EP91121354A patent/EP0490380B1/en not_active Expired - Lifetime
- 1991-12-12 JP JP3350725A patent/JPH04275233A/ja active Pending
- 1991-12-12 IE IE433191A patent/IE914331A1/en not_active Application Discontinuation
- 1991-12-12 AT AT91121354T patent/ATE163264T1/de not_active IP Right Cessation
- 1991-12-12 ES ES91121354T patent/ES2113870T3/es not_active Expired - Lifetime
- 1991-12-12 DK DK91121354T patent/DK0490380T3/da active
- 1991-12-12 DE DE69128926T patent/DE69128926T2/de not_active Expired - Fee Related
- 1991-12-12 KR KR1019910022757A patent/KR100195423B1/ko not_active IP Right Cessation
-
1998
- 1998-03-20 GR GR980400622T patent/GR3026432T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0490380A3 (en) | 1993-03-10 |
GR3026432T3 (en) | 1998-06-30 |
IE914331A1 (en) | 1992-06-17 |
EP0490380A2 (en) | 1992-06-17 |
ZA919695B (en) | 1992-09-30 |
KR920011481A (ko) | 1992-07-24 |
ATE163264T1 (de) | 1998-03-15 |
AU648846B2 (en) | 1994-05-05 |
KR100195423B1 (ko) | 1999-06-15 |
EP0490380B1 (en) | 1998-02-18 |
JPH04275233A (ja) | 1992-09-30 |
ES2113870T3 (es) | 1998-05-16 |
AU8890791A (en) | 1992-06-18 |
DE69128926D1 (de) | 1998-03-26 |
DE69128926T2 (de) | 1998-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU0301601D0 (en) | Bis(n-substituted)-staurosporine derivatives, their use and pharmaceutical composition containing thereof | |
FI950947A (fi) | Oraalisesti annettavat farmaseuttiset formulaatiot | |
IL96995A0 (en) | Pharmaceutical compositions containing pimobendan and their preparation | |
DK0501705T3 (da) | Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje | |
DE69130586D1 (de) | Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten | |
ATE161531T1 (de) | Acridine-1,8-dionderivate als therapeutisches mittel | |
DE69014666D1 (de) | Abgabe von cytotoxischen Mitteln. | |
DK0784613T3 (da) | Colchicinderivater og den terapeutiske anvendelse deraf | |
DK0458589T3 (da) | Behandling af okulær hypertension med en okulær synergistisk kombination | |
DK0490380T3 (da) | Anvendelse af N,N'-bis[3-(ethylamino)propyl]-1,7-heptandiamin og et cytotoksisk middel | |
NZ229422A (en) | Certain (2',5')-oligoadehylate derivatives and pharmaceutical use | |
DK0458587T3 (da) | Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse | |
ATE28566T1 (de) | Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin. | |
EP0454429A3 (en) | Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases | |
ATE145333T1 (de) | Hirudin enthaltende orale arzneimittel | |
ITMI911845A1 (it) | Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico. | |
SE8802323D0 (sv) | 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
DK0678025T3 (da) | Transdermal behandling af cancer med vand-ouopløslig S-camptothecin af den lukkede lactonringform | |
EP0311467A3 (en) | Use of pyrroloû3,2,1-hi¨indole derivatives in the manufacture of a medicament for the treatment of diabetes | |
FR2715658B1 (fr) | Dérivés de N-(3-aminopropyl)-N-phényl-5,6,7,8-tétrahydronaphtalène-2-carboxamide, leur préparation et leur application en thérapeutique. | |
ATE8399T1 (de) | 1,2,4-triazolo(4,3-a)chinolin-1-(2h)-one und diese verbindungen zur pharmazeutischen verwendung. | |
IT1257000B (it) | Derivati dell'eserolina ad attivita` anticolinesterasica, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono. |